Journal article icon

Journal article

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.

Publication status:
Published

Actions


Authors


Expand authors...
Journal:
BLOOD
Volume:
96
Issue:
11
Pages:
825A-825A
Publication date:
2000-11-16
ISSN:
0006-4971
Source identifiers:
331337
Pubs id:
pubs:331337
UUID:
uuid:0b646d3e-469f-4b0f-bff3-cdfb139889a1
Local pid:
pubs:331337
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP